Risk factors for the development of carbapenem-resistant Klebsiella pneumoniae infections in critically ill patients (original) (raw)

Predictive model of antimicrobial-resistant Gram-negative bacteremia at the ED

The American Journal of Emergency Medicine, 2007

A prediction tool for nosocomial multi-drug resistant gram-negative bacilli infections in critically ill patients - prospective observational study

Anupama Vasudevan

BMC Infectious Diseases, 2014

View PDFchevron_right

Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients

Daniel Raymond

Critical Care Medicine, 2003

View PDFchevron_right

Risk Factors for the First Episode of Klebsiella pneumoniae Resistant to Carbapenems Infection in Critically Ill Patients: A Prospective Study

Demosthenes Makris

BioMed Research International, 2013

View PDFchevron_right

Clinical Study Risk Factors for the First Episode of Klebsiella pneumoniae Resistant to Carbapenems Infection in Critically Ill Patients : A Prospective Study

Marios Karvouniaris

2015

View PDFchevron_right

Predicting Antimicrobial Resistance Prevalence and Incidence from Indicators of Antimicrobial Use: What Is the Most Accurate Indicator for Surveillance in Intensive Care Units?

Caroline Quach

PLOS ONE, 2015

View PDFchevron_right

Efficacy of appropriate antimicrobial therapy on the survival of patients with carbapenem non-susceptible Klebsiella pneumoniae infection: A multicenter study in Taiwan

Ching-Tai Huang

Journal of Microbiology, Immunology and Infection, 2015

View PDFchevron_right

Changing trends of carbapenem resistance of escherichia coli and klebsiella pneumoniae strains isolated from intensive care units, inpatient services and outpatient's clinics: a five years retrospective analysis

Yucel Duman

Medicine Science | International Medical Journal, 2018

View PDFchevron_right

Derivation of a Model to Guide Empiric Therapy for Carbapenem Resistant Klebsiella pneumoniae Bloodstream Infection in an Endemic Area

Eran Bellin

Open Forum Infectious Diseases

View PDFchevron_right

Are laboratory-based antibiograms reliable to guide the selection of empirical antimicrobial treatment in patients with hospital-acquired infections

Diego Izaguirre

2007

View PDFchevron_right

Risk factors for carbapenem resistance and outcomes when treating bloodstream infections in a paediatric intensive care unit

Eleni Volakli

Acta Paediatrica, 2019

View PDFchevron_right

Antimicrobial resistance of bacteraemia in the emergency department of a German university hospital (2013–2018): potential carbapenem-sparing empiric treatment options in light of the new EUCAST recommendations

Christoph Spinner

BMC Infectious Diseases

View PDFchevron_right

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011)

Ronald Jones

Diagnostic Microbiology and Infectious Disease, 2014

View PDFchevron_right

Risk factors and predictors of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii mortality in critically ill bacteraemic patients over a 6-year period (2010–15): antibiotics do matter

Evangelos Anastassiou

Journal of Medical Microbiology, 2017

View PDFchevron_right

Optimizing Empirical Antimicrobial Therapy for Infection due to Gram‐Negative Pathogens in the Intensive Care Unit: Utility of a Combination Antibiogram

David Pitrak

Infection Control and Hospital Epidemiology, 2010

View PDFchevron_right

The carbapenem-resistant Enterobacteriaceae score: A bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients

Teena Chopra

American Journal of Infection Control, 2013

View PDFchevron_right

Klebsiella pneumoniae Infections in Intensive Care Unit and Risk Factors for Carbapenem Resistance

Gülsüm Oya Hergünsel

Klimik Dergisi/Klimik Journal, 2021

View PDFchevron_right

Trends, Epidemiology, and Management of Multi-Drug Resistant Gram-Negative Bacterial Infections in the Hospitalized Setting

Elizabeth Cerceo

Antibiotics, 2020

View PDFchevron_right

Comorbidities and Disease Severity as Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Colonization: Report of an Experience in an Internal Medicine Unit

Andrea Ticinesi, Marcello Maggio

PLoS ONE, 2014

View PDFchevron_right

Prevalence and determinants of antimicrobial resistance of gram-negative bacteria in intensive care unit

Thư Minh

Pharmaceutical Sciences Asia

View PDFchevron_right

Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality

Shiri Navon-venezia, Mitchell Schwaber

Antimicrobial Agents and Chemotherapy, 2008

View PDFchevron_right

Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department

Ana Rubia Guedes

Emerging Infectious Diseases, 2020

View PDFchevron_right

Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study

Daryl Depestel

Open forum infectious diseases, 2018

View PDFchevron_right

Carbapenem-resistant Enterobacteriaceae: A retrospective review of treatment and outcomes in a long-term acute care hospital

Zainab AlMusa

American Journal of Infection Control, 2019

View PDFchevron_right

Mortality and Length of Stay in Patients with Bloodstream Infections Due to Drug-Susceptible Versus Drug-Resistant Gram-Negative Bacteria

Jamal Wadi Al Ramahi MD, FIDSA

Mortality and Length of Stay in Patients with Bloodstream Infections Due to Drug-Susceptible Versus Drug-Resistant Gram-Negative Bacteria, 2019

View PDFchevron_right

Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae

Ilana Livshiz-Riven, PhD, RN

American Journal of Infection Control, 2012

View PDFchevron_right

Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification

Marc Scheetz, Michael Postelnick

Antimicrobial Agents and Chemotherapy, 2012

View PDFchevron_right

Observational study of healthcare associated infections and mortality caused by carbapenem resistant Gram-negative bacteria in a Greek ICU

Ioanna OR Joanna Pavlopoulou

2018

View PDFchevron_right

Collective assessment of antimicrobial susceptibility among the most common Gram-negative respiratory pathogens driving therapy in the ICU

Marcela Gonzalez

JAC-Antimicrobial Resistance, 2021

View PDFchevron_right

Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection

Flora Kontopidou

Intensive Care Medicine, 2008

View PDFchevron_right

Bacteraemia in emergency departments: effective antibiotic reassessment is associated with a better outcome

patricia etienne

European Journal of Clinical Microbiology & Infectious Diseases, 2017

View PDFchevron_right

Bacteraemia incidence, causative organisms and resistance patterns, antibiotic strategies and outcomes in a single university hospital ICU: continuing improvement between 2000 and 2013

Alberto Corona

2014

View PDFchevron_right

Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission

Isabelle Alves

Clinical Microbiology and Infection, 2010

View PDFchevron_right

Risk factors for the development of carbapenem-resistant Klebsiella pneumoniae infections in critically ill patients (original) (raw)

Related papers